<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Collection:</title>
  <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/8394" />
  <subtitle />
  <id>http://localhost:8080/xmlui/handle/123456789/8394</id>
  <updated>2026-05-01T18:45:52Z</updated>
  <dc:date>2026-05-01T18:45:52Z</dc:date>
  <entry>
    <title>The Relationship of the Gene Allele Apolipoprotein E with Height in Down Syndrome 21</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/9645" />
    <author>
      <name>Meinapuri, Malinda</name>
    </author>
    <author>
      <name>Amir, Arni</name>
    </author>
    <author>
      <name>Chundrayetti, Eva</name>
    </author>
    <author>
      <name>Efrida, Efrida</name>
    </author>
    <author>
      <name>Susmiati, Susmiati</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/9645</id>
    <updated>2025-01-08T07:22:54Z</updated>
    <published>2023-01-01T00:00:00Z</published>
    <summary type="text">Title: The Relationship of the Gene Allele Apolipoprotein E with Height in Down Syndrome 21
Authors: Meinapuri, Malinda; Amir, Arni; Chundrayetti, Eva; Efrida, Efrida; Susmiati, Susmiati
Abstract: Background: Apolipoprotein E (APOE) is a form of polymorphic protein located on the long arm of&#xD;
chromosome 19 at position 13.2 (19q13.2), translated into three alleles of the gene, namely normal allele&#xD;
3 and dysfunctional allele 2 and 4. Patients with Down's Syndrome Trisomy 21 may have different allele&#xD;
frequencies and combinations of APOE gene genotypes with controls, which can result in decreased&#xD;
cognitive function and inhibition of bone growth. This study aims to analyze the relationship of the&#xD;
Apolipoprotein E Gene Allele with the height of patients with Down Syndrome Trisomy 21. Methods:&#xD;
This research is a cross sectional study with a comparative cross-sectional study design. Results: The&#xD;
sample used was the result of DNA extraction of patients with Down's Syndrome Trisomy 21 as many as&#xD;
33 samples and 33 controls stored in the Biomedical Laboratory, Faculty of Medicine, Andalas University,&#xD;
Padang, Indonesia. The next step is to examine the APOE gene polymorphisms using PCR and sequencing&#xD;
techniques. The results showed that there was a significant relationship between the APOE gene allele&#xD;
and height (p=0.009). Conclusion: This study concluded that there was a significant relationship between&#xD;
the APOE gene allele and the height of patients with Down Syndrome Trisomy 21.&#xD;
Key words: Down's Syndrome, Apolipoprotein E, Height.</summary>
    <dc:date>2023-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Hydrocephalus Mice Model: Choroid Plexus Aquaporin-1 Dynamics Following Cerebrospinal Fluid Drainage</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/9644" />
    <author>
      <name>Baktir, Yusuf</name>
    </author>
    <author>
      <name>Arifin Parenrengi, Muhammad</name>
    </author>
    <author>
      <name>Suryaningtyas, Wihasto</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/9644</id>
    <updated>2025-01-08T07:16:41Z</updated>
    <published>2023-01-01T00:00:00Z</published>
    <summary type="text">Title: Hydrocephalus Mice Model: Choroid Plexus Aquaporin-1 Dynamics Following Cerebrospinal Fluid Drainage
Authors: Baktir, Yusuf; Arifin Parenrengi, Muhammad; Suryaningtyas, Wihasto
Abstract: Background: Aquaporins (AQPs) are a family of membrane proteins that act as channels for water, facilitating&#xD;
its movement across the plasma membrane of cells. Aquaporin1 (AQP1), located in the choroid plexus,&#xD;
is thought to be involved in the process of cerebrospinal fluid (CSF) production. Objective: The objective&#xD;
of this study is to examine the impact of hydrocephalus and cerebrospinal fluid (CSF) drainage on the&#xD;
expression of AQP1 in a mice model of hydrocephalus. Material and Methods: Laboratory experimental&#xD;
study with six groups. Five test groups, one control group, and a rat model of hydrocephalus caused by&#xD;
kaolin were used in the experiment. Results: Hydrocephalus in mice model induced by kaolin, and CSF&#xD;
drainage was performed on the 7th and 14th days group. Immunohistochemical analysis was conducted&#xD;
to examine the presence of AQP1 in the choroid plexus using microscopes. The findings revealed a&#xD;
noticeable decrease in AQP1 expression levels in the choroid plexus, which exhibited a semi-quantitative&#xD;
decline in correlation with the duration of hydrocephalus (p = 0.01). This decrease was observed when&#xD;
comparing the normal group with the hydrocephalus groups on the 7th, 14th, and 21st days following&#xD;
induction. However, after cerebrospinal fluid (CSF) drainage, there was a significant increase in AQP1&#xD;
expression (p &lt; 0.05). Conclusions: This study shows the significant role of AQP1 in CSF production by&#xD;
comparing of AQP1 expression in the choroid plexus of hydrocephalus mice model, with and without CSF&#xD;
drainage. AQP1 expression experiences downregulation in hydrocephalus mice model and upregulation&#xD;
after CSF drainage.&#xD;
Key words: Aquaporin 1, AQP1, Choroid plexus, Hydrocephalus</summary>
    <dc:date>2023-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>The Investigation of The Network Pharmacology and Mechanism of Action of Centella Asiatica Extract on The Atopic Dermatitis Model</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/9643" />
    <author>
      <name>Tungsukruthai, Sucharat</name>
    </author>
    <author>
      <name>Pochairach, Runtikan</name>
    </author>
    <author>
      <name>Krajarng, Aungkana</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/9643</id>
    <updated>2025-01-08T07:15:55Z</updated>
    <published>2023-01-01T00:00:00Z</published>
    <summary type="text">Title: The Investigation of The Network Pharmacology and Mechanism of Action of Centella Asiatica Extract on The Atopic Dermatitis Model
Authors: Tungsukruthai, Sucharat; Pochairach, Runtikan; Krajarng, Aungkana
Abstract: Background: Atopic dermatitis (AD) is a chronic relapsing inflammatory skin condition which has a&#xD;
negative impact on children health. The well-known medicinal plant Centella asiatica extract (CE) is used&#xD;
in herbal skin care products to produce various pharmacological effects in dermatology. However, the&#xD;
molecular target of CE in suppressing inflammatory is largely unknown. Objective: the aim of this study&#xD;
was to examine anti-inflammatory properties and network pharmacology of CE in lipopolysaccharide (LPS)-&#xD;
induced AD in vitro model. Method: RAW264.7 cells were pre-treated with CE and then were stimulated&#xD;
with LPS and then were investigated cell viability, NO production, and the levels of pro-inflammatory&#xD;
mediators. In addition, the Search Tool for Retrieval of Interacting Genes (STRING), SwissTargetPrediction&#xD;
and the Kyoto Encyclopedia of Genes and Genomes (KEGG) were used to construct the defined&#xD;
mechanism of action and network pharmacology. Results: CE showed the potent inhibitory effects on&#xD;
LPS-induced NO. In addition, CE significantly suppressed the expression of iNOS and COX-2, as well&#xD;
as the production of IL-2, IL-6, IL-10, and TNF- α. Furthermore, the network pharmacological analysis&#xD;
revealed the potential role of CE in biological processes such as regulating JAK/STATs pathway and&#xD;
inhibiting proinflammatory cytokines both of which were linked to AD pathogenesis. Conclusion: Our&#xD;
findings confirm our hypothesis that CE could be developed as a therapeutic therapy for atopic dermatitis&#xD;
due to its pharmacological action and signaling mechanism in the modulation of allergic skin inflammation.&#xD;
Key words: Atopic dermatitis, Centella asiatica, Network pharmacology, Skin inflammation</summary>
    <dc:date>2023-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Standardization Study of Trunks and Branches of Xanthoceras Sorbifolia Bunge</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/9642" />
    <author>
      <name>Qirigeer, Qirigeer</name>
    </author>
    <author>
      <name>Bagenna, Bagenna</name>
    </author>
    <author>
      <name>Laxinamujila, Laxinamujila</name>
    </author>
    <author>
      <name>Malchinkhuu, Munkhzol</name>
    </author>
    <author>
      <name>Sodnomtseren, Purevsuren</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/9642</id>
    <updated>2025-01-08T07:14:06Z</updated>
    <published>2023-01-01T00:00:00Z</published>
    <summary type="text">Title: Standardization Study of Trunks and Branches of Xanthoceras Sorbifolia Bunge
Authors: Qirigeer, Qirigeer; Bagenna, Bagenna; Laxinamujila, Laxinamujila; Malchinkhuu, Munkhzol; Sodnomtseren, Purevsuren
Abstract: Introduction: Although there is a wide range of studies on phytochemistry and pharmacology, there&#xD;
currently needs to be a standard quality control method or index for assessing the components of X.&#xD;
sorbifolium Bunge to ensure quality. Objectives: This study aimed to determine some quality parameters&#xD;
of the standardization of trunks and branches of Xanthoceras sorbifolia Bunge. Methods: The cellular&#xD;
diagnostic structures of trunks and branches of the plant were defined by “Olympus” light microscopy.&#xD;
Biologically active compounds were identified using TLC and HPLC, and the main biologically active&#xD;
compounds’ contents were determined by HPLC methods. Some quality parameters of trunks and&#xD;
branches of X. sorbifolium Bunge were determined by Chinese Pharmacopoeia methods. Results:&#xD;
Microstructure of trunk and branch of the X. sorbifolia Bunge was defined. Some quality parameters of&#xD;
trunks and branches of X. sorbifolia Bunge collected from seven locations in Inner Mongolia were defined&#xD;
as: moisture 4.8-6.1%, total ash 5.57-7.3%, acid-insoluble ash 1.3-2.7%, alcohol-soluble extractive 8.97-&#xD;
11.63%. The fingerprints of TLC to reveal epicatechin and HPLC to reveal epicatechin, dihydromyricetin,&#xD;
dihydroquercetin, myricetin, quercetin, and naringenin were defined. Some flavonoid contents in trunks&#xD;
and branches of X. sorbifolia Bunge collected from seven locations in Inner Mongolia were determined&#xD;
according to the developed and validated method as: epicatechin 6.39-11.687 mg/g, dihydroquercetin&#xD;
1.02-1.833 mg/g, and myricetin 0.02-2.693 mg/g. Conclusion: The standardization criteria for the trunk&#xD;
and branches of X. sorbifolia Bunge were defined. Quality parameters and contents of epicatechin,&#xD;
dihydroquercetin, and myricetin were different in Xanthoceras sorbifolia Bunge collected from seven&#xD;
locations in Inner Mongolia.&#xD;
Key words: Epicatechin, Dihydroquercetin, Myricetin, Mongolian medicine</summary>
    <dc:date>2023-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

